These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32944474)

  • 61. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Muscle specific kinase: organiser of synaptic membrane domains.
    Ghazanfari N; Fernandez KJ; Murata Y; Morsch M; Ngo ST; Reddel SW; Noakes PG; Phillips WD
    Int J Biochem Cell Biol; 2011 Mar; 43(3):295-8. PubMed ID: 20974278
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ["Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase].
    Hain B; Hanisch F; Deschauer M
    Nervenarzt; 2004 Apr; 75(4):362-7. PubMed ID: 15042294
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Molecular mechanisms underlying the formation and maintenance of neuromuscular junctions and a possible therapeutic approach.].
    Eguchi T; Tezuka T; Miyoshi S; Yamanashi Y
    Clin Calcium; 2017; 27(3):413-419. PubMed ID: 28232656
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis.
    Xu K; Jha S; Hoch W; Dryer SE
    Neuroscience; 2006 Dec; 143(3):655-9. PubMed ID: 17081697
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Myasthenia gravis. Information for the anesthetist and critical care physician].
    Marquardt J; Reuther P
    Anaesthesist; 1984 May; 33(5):207-11. PubMed ID: 6465508
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.
    Marino M; Scuderi F; Samengo D; Saltelli G; Maiuri MT; Shen C; Mei L; Sabatelli M; Pani G; Antonini G; Evoli A; Bartoccioni E
    PLoS One; 2015; 10(8):e0135378. PubMed ID: 26284792
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Myasthenic Crisis in an Elderly Patient with Positive Antibodies against Acetylcholine and Anti-MuSK, Successfully Treated with Noninvasive Mechanical Ventilation.
    Fernández JA; Fernández-Valiñas A; Hernández D; Orozco J; Lugo A
    Case Rep Crit Care; 2015; 2015():624718. PubMed ID: 26783473
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Functional Human-on-a-Chip Autoimmune Disease Model of Myasthenia Gravis for Development of Therapeutics.
    Smith VM; Nguyen H; Rumsey JW; Long CJ; Shuler ML; Hickman JJ
    Front Cell Dev Biol; 2021; 9():745897. PubMed ID: 34881241
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mouse models of myasthenia gravis.
    Ban J; Phillips WD
    Curr Pharm Des; 2015; 21(18):2468-86. PubMed ID: 25777761
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
    Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
    Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Introducing Autoimmunity at the Synapse by a Novel Animal Model of Experimental Autoimmune Myasthenia Gravis.
    Wang J; Xiao Y; Zhang K; Luo B; Shen C
    Neuroscience; 2018 Mar; 374():264-270. PubMed ID: 29421431
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Double Seronegative Myasthenia Gravis: A Systematic Review.
    Bacchi S; Kramer P; Chalk C
    Can J Neurol Sci; 2018 Jan; 45(1):62-67. PubMed ID: 29334041
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Myasthenia gravis.
    Pourmand R
    Dis Mon; 1997 Feb; 43(2):65-109. PubMed ID: 9118787
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes].
    Berrih-Aknin S; Le Panse R
    Rev Med Interne; 2014 Jul; 35(7):413-20. PubMed ID: 24156976
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis.
    Mori S; Kubo S; Akiyoshi T; Yamada S; Miyazaki T; Hotta H; Desaki J; Kishi M; Konishi T; Nishino Y; Miyazawa A; Maruyama N; Shigemoto K
    Am J Pathol; 2012 Feb; 180(2):798-810. PubMed ID: 22142810
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Myasthenia Gravis Presentation After a Cervical Laminectomy With Fusion.
    Deters D; Fowler SL; Orozco R; Smith PR; Spurlock S; Blackmon D; Thomas S
    Dimens Crit Care Nurs; 2016; 35(4):190-4. PubMed ID: 27258955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.